Evidence map›Paper›PMID 26955646›Full record

ArticleCurrent opinion in behavioral sciences2016

Stop signs in hippocampal insulin signaling: the role of insulin resistance in structural, functional and behavioral deficits.

Jim R Fadel, Lawrence P Reagan

Abstract read
In one paragraph

Article in Current opinion in behavioral sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jim R FadelDepartment of Pharmacology, Physiology and Neuroscience, University of South Carolina School of Medicine, Columbia, SC, USA.
Lawrence P ReaganDepartment of Pharmacology, Physiology and Neuroscience, University of South Carolina School of Medicine, Columbia, SC, USA; WJB Dorn Veterans Affairs Medical Center, Columbia, SC, USA.
University of South Carolina · USWm. Jennings Bryan Dorn VA Medical Center · US

Funding

Hypocretin/orexin modulation of cognitive correlates of brain agingR01AG050518 · NIA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI JIM R FADEL · 2015 to 2026
$2.1M
Aging, acetylcholine and the hypothalamusR01AG030646 · NIA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI FADEL, JIM R · 2008 to 2011
$1.2M
Decreased CNS leptin activity in co-morbid depression and obesityI01BX001804 · VA · VETERANS HEALTH ADMINISTRATION · PI REAGAN, LAWRENCE P · 2013 to 2021
–
BLRD VA I01 BX001804NIA NIH HHS R01 AG030646NIA NIH HHS R01 AG050518
6 · The paper itself

Abstract

In peripheral tissues insulin activates signaling cascades to facilitate glucose uptake from the blood into tissues like liver, muscle and fat. While insulin appears to play a minor role in the regulation of glucose uptake in the central nervous system (CNS), insulin is known to play a major role in regulating synaptic plasticity in brain regions like the hippocampus. The concept that insulin regulates hippocampal neuroplasticity is further supported from animal models of type 2 diabetes (T2DM) and Alzheimer's disease (AD). The goal of this review is to provide an overview of these studies, as well as the studies that have examined whether deficits in hippocampal insulin signaling are amenable to intervention strategies.

Identifiers

PMID26955646
PMCPMC4778085
OpenAlexW2235429109

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.